HopeStage
Study directory

Schizophrenia studies

Schizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.

Back to overview
More filters: keywords, city, remote
453studies shown
Showing 109-120 of 453
Drug study icon
RecruitingNCT05823532

Anti-Inflammatory Challenge in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Atlanta
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugA study involving a medication or substance.From 18 Years to 55 Years
Countries
United States
Sponsor
Emory University
Condition
Schizophrenia
Drug study icon
RecruitingACTRN12619001471178

Bazedoxifene – A New Selective Estrogen Receptor Modulator Treatment for Men with Schizophrenia

The registry describes this research topic: “Bazedoxifene – A New Selective Estrogen Receptor Modulator Treatment for Men with Schizophrenia”. This is an interventional study.

In Australia
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 65 Years
Countries
Australia
Sponsor
Monash University Foundation
Condition
Schizophrenia
Drug study icon
RecruitingNCT06969755

Biomarkers to Enhance Early Schizophrenia Treatment

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Birmingham
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 35 Years
Countries
United States, Canada
Sponsor
Northwell Health
Condition
Schizophrenia
Device study icon
RecruitingNCT05276050

Circuitry-Guided Smoking Cessation in Schizophrenia (UH3)

This summary needs review. Please check the official study record and contact the research team for details.

In Houston
Why is this study shown?

This study is directly about Schizophrenia.

Schizophrenia, AddictionDeviceA study involving a tool, app, wearable, test, or medical device.From 22 Years to 65 Years
Countries
United States
Sponsor
The University of Texas Health Science Center, Houston
Condition
Schizophrenia, Addiction
Other study type icon
RecruitingACTRN12605000384651

CONSTA in Polynesian Subjects

The registry describes this research topic: “CONSTA in Polynesian Subjects”. This is an observational study.

In New Zealand
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaObservationalA study where researchers collect information without assigning a treatment.From Not stated to Not stated
Countries
New Zealand
Sponsor
Janssen-Cilag
Condition
Schizophrenia
Drug study icon
RecruitingNCT03794076

Cromoglicate Adjunctive Therapy for Outpatients With Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Pittsburgh
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Vishwajit Nimgaonkar, MD PhD
Condition
Schizophrenia
Device study icon
RecruitingNCT06257056

Deep Brain Stimulation for Psychosis

This summary needs review. Please check the official study record and contact the research team for details.

In Dallas
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDeviceFrom 22 Years to 70 Years
Countries
United States
Sponsor
Bradley Lega
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.